Lovotibeglogene Autotemcel + Iron Chelators Interaction
Majorinteraction on record
Description
Drug-drug interactions must be considered with mobilization and myeloablative conditioning. Discontinue at least 7 days prior to mobilization or conditioning. Myelosuppressive iron chelators should not restart sooner than 6 months post-infusion.
Mechanism
Interactions with mobilization process and myeloablative conditioning agent
Source: NLP:lovotibeglogene autotemcel